Anna is a recipient of the @histochemicalsoc.bsky.social Cornerstone Award!
Anna is a recipient of the @histochemicalsoc.bsky.social Cornerstone Award!
📅 Nov. 11 | 13:00–14:00 (Turkey time)
🔗 Join the presentation: acibadem-edu-tr.zoom.us/j/95890909223
#Histochemistry #Cytochemistry
📅 Nov. 11 | 13:00–14:00 (Turkey time)
🔗 Join the presentation: acibadem-edu-tr.zoom.us/j/95890909223
#Histochemistry #Cytochemistry
📅 Deadline: Friday, Oct 30th
🔗 Learn more and apply: hcs.memberclicks.net/keystone-gra...
#Histochemistry #EarlyCareerResearchers #Postdocs
📅 Deadline: Friday, Oct 30th
🔗 Learn more and apply: hcs.memberclicks.net/keystone-gra...
#Histochemistry #EarlyCareerResearchers #Postdocs
The meeting featured excellent science and opportunities to connect with international colleagues.
Thank you to our hosts for their generous hospitality and a successful meeting!
The meeting featured excellent science and opportunities to connect with international colleagues.
Thank you to our hosts for their generous hospitality and a successful meeting!
Click to read for FREE: journals.sagepub.com/doi/full/10....
#extracellularmatrix #glycosaminoglycan #histochemistry
Click to read for FREE: journals.sagepub.com/doi/full/10....
#extracellularmatrix #glycosaminoglycan #histochemistry
Read now: https://ow.ly/SPmO50ZSr1P
The Histochemical Society (HCS) and Journal (JHC)
Read now: https://ow.ly/SPmO50ZSr1P
The Histochemical Society (HCS) and Journal (JHC)
The HCS Immunohistochemistry & Immunofluorescence Course continues this week at @mblscience.bsky.social in Woods Hole, with participants putting concepts into practice in the Loeb Lab!
#Immunohistochemistry #Immunofluorescence #Histochemistry
The HCS Immunohistochemistry & Immunofluorescence Course continues this week at @mblscience.bsky.social in Woods Hole, with participants putting concepts into practice in the Loeb Lab!
#Immunohistochemistry #Immunofluorescence #Histochemistry
Click to read for FREE: journals.sagepub.com/doi/full/10....
#extracellularmatrix #glycosaminoglycan #histochemistry
Click to read for FREE: journals.sagepub.com/doi/full/10....
#extracellularmatrix #glycosaminoglycan #histochemistry
buff.ly/9t2GKwQ
#binanorbiotech #nanoplastics #polystyrene #rat #MaleFertility
buff.ly/9t2GKwQ
#binanorbiotech #nanoplastics #polystyrene #rat #MaleFertility
Check out the latest articles at journals.sagepub.com/toc/JHC/curr...
#Science #Histochemistry #Cytochemistry
Check out the latest articles at journals.sagepub.com/toc/JHC/curr...
#Science #Histochemistry #Cytochemistry
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)
• ↓39% CO activity in superficial cortical layers (I–II) of the PCC in AD patients vs. age-matched controls (p < 0.01)